You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Ajanta Pharma Ltd"

Ajanta Pharma Ltd Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992

  • 24/02/2021
  • |
  • bse

Ajanta Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 22/02/2021
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 12/02/2021
  • |
  • bse

Ajanta Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 03/02/2021
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 02/02/2021
  • |
  • bse

Ajanta Pharma Ltd Outcome Of Board Meeting - Quarterly Results

  • 02/02/2021
  • |
  • bse

Ajanta Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 25/01/2021
  • |
  • bse

Ajanta Pharma Ltd Board Meeting Intimation for Considering And Approving Unaudited Consolidated & Standalone Financial

  • 23/01/2021
  • |
  • bse

Ajanta Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 19/01/2021
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 15/01/2021
  • |
  • bse

Ajanta Pharma Ltd Statement Of Investor Complaints For The Quarter Ended December 2020

  • 14/01/2021
  • |
  • bse

Ajanta Pharma Ltd Shareholding for the Period Ended December 31 2020

  • 11/01/2021
  • |
  • bse

Ajanta Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 08/01/2021
  • |
  • bse

Ajanta Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 08/01/2021
  • |
  • bse

Ajanta Pharma Ltd Closure of Trading Window

  • 31/12/2020
  • |
  • bse

Ajanta Pharma Ltd Completion Of Extinguishment Of Shares

  • 30/12/2020
  • |
  • bse

Ajanta Pharma Ltd Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement

  • 25/12/2020
  • |
  • bse

Ajanta Pharma Ltd Post Buyback Offer

  • 25/12/2020
  • |
  • bse

Ajanta Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 17/12/2020
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 16/12/2020
  • |
  • bse
.